ArticleFrontiers in public health2025

Multinational cost-effectiveness analysis of pembrolizumab combined with chemotherapy as first-line treatment for advanced biliary tract cancer.

Yuxuan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.